Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

NovoCure Limited NVCR

Set alert

Price alert · NVCR

All alert types
13.45 USD +0.24 +1.82%

As of Nov 3, 1:00 PM ET

Bid
13.44 × 2
Ask
13.46 × 1
13.21 Day range 13.56
9.82 52-week range 21.45
YTD
+4.03%
1 year
+9.98%
Open
13.30
Prev close
13.21
Mkt cap
1.57B
Vol
370.97K
Avg vol
1.44M
EPS
-1.06
P/E
0.00
Div yield
0.00%
More statistics
Low
13.21
High
13.56
Forward P/E
-17.87
Beta
1.08
Short ratio
9.27
Inst. own
90.52%
Dividend
0.00
Ex-div date
Earnings
Feb 25, 2027
50-d avg
15.79
200-d avg
14.82
1y target
26.43

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 4, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
  • Oct 30, 2026Rating: Evercore ISI Group · Outperform → Outperform
  • Oct 30, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (32)
NameDateAgo
SMA: BearishOct 1, 20261 month ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 1, 20263 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BullishApr 1, 20267 months ago
SMA: BearishFeb 1, 20251 year ago
SMA: BullishNov 1, 20242 years ago
SMA: BearishSep 1, 20242 years ago
MACD: Buy SignalJun 1, 20242 years ago
SMA: BullishMay 1, 20242 years ago
SMA: BearishMar 1, 20233 years ago
SMA: BullishJan 1, 20233 years ago
SMA: BearishDec 1, 20223 years ago
SMA: BullishNov 1, 20224 years ago
SMA: BearishSep 1, 20224 years ago
SMA: BullishAug 1, 20224 years ago
SMA: BearishOct 1, 20215 years ago
MACD: Sell SignalSep 1, 20215 years ago
SMA: BearishJul 1, 20215 years ago

Newest 20 of 32.

Analyst view

Consensus: buy

Buy
Price target (mean) 26.43 +96.5% upside
Target (low)
17.00
Target (mean)
26.43
Target (high)
52.00
Ratings (0m) 7 4 buy · 3 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold3
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NVCR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.24138-0.31 – -0.15-0.22-9.7%188.98M+8.4%6
Next quarter-0.21-0.27 – -0.11-0.62+66.1%188.60M+8.4%4
Current year-1.05-1.06 – -1.03-1.22+13.9%739.97M+12.9%4
Next year-0.77494-1.06 – -0.22459-1.05+26.2%808.29M+9.2%7

Upgrades and downgrades

The latest rating changes

NVCR analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Oct 30, 2026Evercore ISI GroupMaintainedOutperformOutperform
Jul 24, 2026WedbushMaintainedNeutralNeutral
Jul 23, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 18, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 4, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
May 1, 2026Evercore ISI GroupMaintainedOutperformOutperform
Apr 16, 2026WedbushReiteratedNeutralNeutral
Feb 26, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 15, 2026WedbushReiteratedNeutralNeutral
Jan 13, 2026HC Wainwright & Co.MaintainedBuyBuy
Oct 30, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 27, 2025JP MorganMaintainedNeutralNeutral
Jul 25, 2025Wells FargoDowngradeOverweightEqual-Weight
Jul 8, 2025Ladenburg ThalmannInitiated—Buy
Jun 27, 2025Piper SandlerReiteratedOverweightOverweight
Apr 23, 2025Piper SandlerMaintainedOverweightOverweight
Apr 16, 2025WedbushMaintainedNeutralNeutral
Apr 10, 2025JP MorganMaintainedNeutralNeutral
Jan 14, 2025HC Wainwright & Co.ReiteratedBuyBuy
Dec 13, 2024Piper SandlerMaintainedOverweightOverweight
Dec 3, 2024HC Wainwright & Co.MaintainedBuyBuy
Dec 2, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 2, 2024Evercore ISI GroupUpgradeIn-LineOutperform
Nov 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 16, 2024HC Wainwright & Co.UpgradeNeutralBuy
Oct 1, 2024Evercore ISI GroupMaintainedIn-LineIn-Line
Jul 26, 2024Wells FargoMaintainedOverweightOverweight